Advances in Assessment and Cognitive Neurorehabilitation of HIV-related Neurocognitive Impairment

Overview

Journal Brain Commun

Publisher Oxford University Press

Specialty Neurology

Date 2024 Dec 27

PMID 39726816

Authors

Elia L Fischer

Alexis Renaud

Petr Grivaz

Giovanni Di Liberto

Philippe Ryvlin

Matthias Cavassini

Renaud A Du Pasquier

Arseny A Sokolov

Affiliations

Soon will be listed here.

Abstract

Neurocognitive impairment (NCI) is present in around 40% of people with HIV and substantially affects everyday life, adherence to combined antiretroviral therapy (cART) and overall life expectancy. Suboptimal therapy regimen, opportunistic infections, substance abuse and highly prevalent psychiatric co-morbidities contribute to NCI in people with HIV. In this review, we highlight the need for efficacious treatment of HIV-related NCI through pharmacological approaches and cognitive neurorehabilitation, discussing recent randomized controlled trials in this domain. We also discuss the benefits of a thorough and interdisciplinary diagnostic work-up between specialists in neurology, psychiatry, neuropsychology and infectious diseases, helping to disentangle the various factors contributing to cognitive complaints and deficits in people with HIV. While the advent of cART has contributed to slowing the progression of cognitive deficits in people with HIV and reducing the prevalence of HIV-associated dementia, NCI persists at a significant rate. Adjuvant stimulating or neuroprotective pharmacological agents have shown some potential benefits. Despite promising outcomes, studies on cognitive neurorehabilitation of HIV-related NCI remain sparse and limited in terms of methodological aspects. The access to cognitive neurorehabilitation is also restricted, in particular at the global scale. Novel technology bears a significant potential for restoring cognitive function in people with HIV, affording high degrees of standardization and personalization, along with opportunities for telerehabilitation. Entertaining serious video game environments with immersive graphics can further promote patient motivation, training adherence and impact on everyday life, as indicated by a growing body of evidence, including in seropositive children and older individuals in Africa. Upon validation of technology-assisted cognitive neurorehabilitation for HIV-related NCI in large-scale randomized controlled trials with state-of-the-art methodology, these approaches will promote socio-professional reintegration and quality of life of people with HIV.

References

Novack T, Banos J, Alderson A, Schneider J, Weed W, Blankenship J . UFOV performance and driving ability following traumatic brain injury. Brain Inj. 2006; 20(5):455-61. DOI: 10.1080/02699050600664541. View

Livelli A, Orofino G, Calcagno A, Farenga M, Penoncelli D, Guastavigna M . Evaluation of a Cognitive Rehabilitation Protocol in HIV Patients with Associated Neurocognitive Disorders: Efficacy and Stability Over Time. Front Behav Neurosci. 2015; 9:306. PMC: 4644912. DOI: 10.3389/fnbeh.2015.00306. View

Santos G, Locatelli I, Metral M, Calmy A, Doco Lecompte T, Nadin I . Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland. Open Forum Infect Dis. 2019; 6(7):ofz277. PMC: 6612860. DOI: 10.1093/ofid/ofz277. View

Bryant V, Whitehead N, Burrell 2nd L, Dotson V, Cook R, Malloy P . Depression and Apathy Among People Living with HIV: Implications for Treatment of HIV Associated Neurocognitive Disorders. AIDS Behav. 2014; 19(8):1430-7. PMC: 4508233. DOI: 10.1007/s10461-014-0970-1. View

Zipursky A, Gogolishvili D, Rueda S, Brunetta J, Carvalhal A, Mccombe J . Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature. AIDS. 2013; 27(15):2385-401. PMC: 3814629. DOI: 10.1097/QAD.0b013e328363bf56. View

Gavegnano C, Haile W, Hurwitz S, Tao S, Jiang Y, Schinazi R . Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro. J Neuroinflammation. 2019; 16(1):182. PMC: 6764124. DOI: 10.1186/s12974-019-1565-6. View

Anderson A, Letendre S, Ances B . CROI 2022: neurologic complications of HIV-1, SARS-CoV-2, and other pathogens. Top Antivir Med. 2022; 30(3):475-489. PMC: 9473895. View

Cody S, Fazeli P, Vance D . Feasibility of a Home-Based Speed of Processing Training Program in Middle-Aged and Older Adults With HIV. J Neurosci Nurs. 2015; 47(4):247-54. PMC: 4545608. DOI: 10.1097/JNN.0000000000000147. View

Ciccarelli N . Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update?. Infection. 2019; 48(1):37-42. DOI: 10.1007/s15010-019-01373-8. View

10.

Heaton R, Franklin D, Ellis R, McCutchan J, Letendre S, LeBlanc S . HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2010; 17(1):3-16. PMC: 3032197. DOI: 10.1007/s13365-010-0006-1. View

11.

Boivin M, Nakasujja N, Sikorskii A, Opoka R, Giordani B . A Randomized Controlled Trial to Evaluate if Computerized Cognitive Rehabilitation Improves Neurocognition in Ugandan Children with HIV. AIDS Res Hum Retroviruses. 2016; 32(8):743-55. PMC: 4971428. DOI: 10.1089/AID.2016.0026. View

12.

Hsu W, Rowles W, Anguera J, Anderson A, Younger J, Friedman S . Assessing Cognitive Function in Multiple Sclerosis With Digital Tools: Observational Study. J Med Internet Res. 2021; 23(12):e25748. PMC: 8759021. DOI: 10.2196/25748. View

13.

Di Lorito C, Long A, Byrne A, Harwood R, Gladman J, Schneider S . Exercise interventions for older adults: A systematic review of meta-analyses. J Sport Health Sci. 2020; 10(1):29-47. PMC: 7858023. DOI: 10.1016/j.jshs.2020.06.003. View

14.

Marra C, Zhao Y, Clifford D, Letendre S, Evans S, Henry K . Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS. 2009; 23(11):1359-66. PMC: 2706549. DOI: 10.1097/QAD.0b013e32832c4152. View

15.

Lampit A, Hallock H, Valenzuela M . Computerized cognitive training in cognitively healthy older adults: a systematic review and meta-analysis of effect modifiers. PLoS Med. 2014; 11(11):e1001756. PMC: 4236015. DOI: 10.1371/journal.pmed.1001756. View

16.

Cooley S, Nelson B, Rosenow A, Westerhaus E, Cade W, Reeds D . Exercise Training to Improve Brain Health in Older People Living With HIV: Study Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2023; 12:e41421. PMC: 10131751. DOI: 10.2196/41421. View

17.

Robertson K, Oladeji B, Jiang H, Kumwenda J, Supparatpinyo K, Campbell T . Human Immunodeficiency Virus Type 1 and Tuberculosis Coinfection in Multinational, Resource-limited Settings: Increased Neurological Dysfunction. Clin Infect Dis. 2018; 68(10):1739-1746. PMC: 6495021. DOI: 10.1093/cid/ciy718. View

18.

Milanini B, Ciccarelli N, Fabbiani M, Baldonero E, Limiti S, Gagliardini R . Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE). Clin Neuropsychol. 2016; 30(sup1):1457-1468. DOI: 10.1080/13854046.2016.1183048. View

19.

Vance D, Fazeli P, Azuero A, Wadley V, Raper J, Ball K . Can Individualized-Targeted Computerized Cognitive Training Benefit Adults with HIV-Associated Neurocognitive Disorder? The Training on Purpose Study (TOPS). AIDS Behav. 2021; 25(12):3898-3908. DOI: 10.1007/s10461-021-03230-y. View

20.

Simioni S, Cavassini M, Annoni J, Metral M, Iglesias K, Rimbault Abraham A . Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study. Neurology. 2013; 80(6):553-60. DOI: 10.1212/WNL.0b013e3182815497. View